What Is Epic Beacon? Epic’s Oncology EHR Module

Epic Beacon is the oncology module within Epic’s electronic health record (EHR) system, designed specifically for cancer care. It allows physicians and other providers to create treatment plans based on standardized protocols while also supporting easy modifications for individual patients. If you’ve come across this term at a hospital, in a job listing, or while navigating cancer treatment, Beacon is essentially the software that helps oncology teams plan, track, and coordinate chemotherapy and other cancer therapies.

How Beacon Fits Into Cancer Treatment

Cancer treatment is uniquely complex compared to most areas of medicine. A single patient may receive multiple drugs in precise combinations, timed across cycles that stretch over weeks or months. Doses often need adjustment based on lab results, side effects, or how the cancer responds. Beacon was built to handle that complexity inside the same medical record system a hospital already uses for everything else.

At its core, Beacon lets oncologists select from established treatment protocols (the drug combinations and schedules that clinical evidence supports for a given cancer type) and then tailor them to a specific patient. Rather than writing chemotherapy orders from scratch each time, a physician pulls up a protocol, adjusts it as needed, and the system populates the correct drugs, doses, timing, and supportive medications. This reduces the chance of errors in a setting where even small dosing mistakes can be dangerous.

Treatment Plan Building

Treatment plans in Beacon follow a structured process. A protocol content team, typically made up of pharmacists and clinical specialists, builds each plan according to the treatment protocol’s specifications. These plans include not just the chemotherapy drugs themselves but also pre-medications, hydration orders, lab requirements, and nursing instructions. Once built, the plans go through validation by the broader care team, including the prescribing physician, nurses, coordinators, and pharmacists, before being finalized in the system.

The plans use standardized language for procedures and instructions. For example, lab collection windows are specified in minutes rather than hours or percentages, and restrictions like “peripheral draw only” are embedded directly into the plan. This level of detail matters because oncology nurses and pharmacists rely on these instructions to safely prepare and administer treatments. Standardization means that a nurse at one clinic location sees the same plan format and instructions as a nurse at another, reducing confusion and variability.

Clinical Trial Management

Beacon plays a significant role in managing patients enrolled in cancer clinical trials. Research operations teams use Beacon to build treatment plans for both standard-of-care treatments and investigational drug protocols. At institutions like City of Hope, protocol content administrators create each Beacon treatment plan according to the trial protocol’s exact specifications, then route it through the study team for review before it goes live.

This is especially valuable because clinical trials have strict requirements about dosing, timing, and monitoring that go beyond routine cancer care. Having those requirements built directly into the treatment plan, rather than tracked on paper or in a separate system, helps ensure that trial protocols are followed precisely. It also keeps all of a patient’s treatment data in one place, which simplifies reporting and safety monitoring.

Who Uses Beacon Day to Day

Beacon isn’t just a physician tool. It touches nearly every role in an oncology practice. Oncologists use it to select and modify treatment plans. Pharmacists verify orders and check for drug interactions or dose adjustments. Nurses use it to see exactly what needs to be administered during each treatment visit, including the sequence and timing of infusions, pre-medications, and any special instructions. Coordinators use it to schedule treatment cycles and track where a patient is in their overall plan.

The system supports both adult and pediatric oncology, and it’s also used by non-oncology providers who may be involved in a cancer patient’s care. Because Beacon sits inside the broader Epic ecosystem, any provider with access to a patient’s chart can see their oncology treatment history, active medications, and upcoming treatment schedule.

How Beacon Differs From Standard Epic

Epic’s main EHR handles the kinds of tasks common across all medical specialties: charting visits, ordering labs, prescribing medications, managing referrals. Beacon layers oncology-specific functionality on top of that foundation. The key difference is the concept of a multi-step, multi-cycle treatment plan. Most medications in a standard EHR are straightforward: take this pill once a day. Chemotherapy regimens involve complex combinations of drugs given on specific days within repeating cycles, with dose calculations often based on body surface area or weight, and rules governing when to hold, reduce, or escalate treatment.

Beacon also provides what Epic calls “comprehensive decision support,” meaning the system can flag potential issues, suggest dose modifications based on lab values, or alert providers when a patient’s results fall outside expected parameters. This kind of built-in safety checking is critical in oncology, where the drugs being administered are inherently toxic and the margin between a therapeutic dose and a harmful one can be narrow.

Epic’s Broader AI Roadmap

Epic has been rolling out AI-powered tools across its platform, and these are beginning to touch oncology workflows as well. As of 2025, Epic offers AI-generated clinical insights through its assistant for clinicians and an AI-powered guideline builder. Additional AI features are scheduled through 2026, including tools that draft responses to patient messages, provide contextual summaries of patient records, and review clinical information in real time. While these tools aren’t Beacon-specific, they operate within the same ecosystem and will increasingly shape how oncology teams interact with patient data and treatment decisions.